Patient-centric approaches thrive on wearables and remote access in trials. Experts discuss the use of artificial intelligence (AI) and patient-centric strategies in oncology clinical trials.

Dec 23, 2024 · The companies have also been investigating their therapies this year in indications beyond metabolic diseases, including cardiovascular and respiratory.. The Phase III SELECT study (NCT03574597) showed that Novo Nordisk’s semaglutide significantly reduced hospital admissions and overall length of hospital stay for adults with obesity or overweight with established cardiovascular disease (CVD ...

May 19, 2025 · Most clinical trial conferences now have a stream dedicated to patient engagement or patient centricity, and these streams are always filled with delegates who are ready to openly speak about how they can improve designs for patients, showing that the industry is starting to consider this way of thinking. These approaches have been more heavily adopted in the rare disease space, where ...

Jan 17, 2025 · The clinical trial sector reflects on what it believes will be the biggest difficulties of 2025. Image credit: Shutterstock / 3rdtimeluckystudio It has been a turbulent time for the pharmaceutical industry – especially in regard to the clinical trial sector. From reduced investment, to …

About Us. Clinicaltrialsarena.com is one of a network of 40+ proprietary B2B websites, with an unrivalled global audience of active decision makers, influencers, and opinion leaders across the world with a combined readership of 55 million industry professionals each year.. As part of GlobalData, we have access to over 1bn data points including companies, deals, projects and forecasts, and trends.

Patient-centric approaches thrive on wearables and remote access in trials. A transformative application of artificial intelligence (AI) in drug development lies in its potential to match the right patient population…

Q2 2024 update: social responsibility related hiring actvity in the pharma industry. The global pharmaceutical industry experienced a 22% rise in new job postings related to social responsibility in Q2 2024 compared…

Mar 6, 2025 · Tris Pharma has announced positive data from two Phase III trials of cebranopadol, as well as positive data from a human abuse potential (HAP) study to compare the therapy against various opioids. Image credit: Shutterstock / T Schneider. Tris Pharma has reported another Phase III win with its ...

Apr 10, 2025 · Pfizer initiated a Phase II trial in early March 2025 for its next-generation antiviral drug candidate, ibuzatrelvir. The trial, ‘An Interventional Efficacy and Safety, Phase III, Double-Blind, 2-Arm Study to Investigate Orally Administered Ibuzatrelvir Compared with Placebo in Non-Hospitalized Symptomatic Adult and Adolescent Participants with Covid-19 Who Are at High Risk of Progressing to ...

Clinicaltrialsarena.com covers every aspect of the drug development and research process, from conception to pre-FDA approval.. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone – from senior management through to research and QA staff – …